TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Ame Bioscience AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,627
|
516
|
1,905 |
| Financial expenses |
2
|
2
|
9 |
| Earnings before taxes |
329
|
97
|
391 |
| Total assets |
857
|
471
|
770 |
| Current assets |
857
|
471
|
769 |
| Current liabilities |
313
|
110
|
104 |
| Equity capital |
544
|
361
|
666 |
| - share capital |
8
|
9
|
9 |
| Employees (average) |
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
63.5%
|
76.6%
|
86.5% |
| Turnover per employee |
1,627
|
516 | |
| Profit as a percentage of turnover |
20.2%
|
18.8%
|
20.5% |
| Return on assets (ROA) |
38.6%
|
21.0%
|
51.9% |
| Current ratio |
273.8%
|
428.2%
|
739.4% |
| Return on equity (ROE) |
60.5%
|
26.9%
|
58.7% |
| Change turnover |
1,137
|
-1,268
|
-420 |
| Change turnover % |
232%
|
-71%
|
-18% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.